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Immune tolerance requires regulatory T (Treg) cells
to prevent autoimmune disease, with the transcrip-
tion factor Foxp3 functioning as the critical regulator
of Treg cell development and function. We report
here that Foxp3 was lethal to developing Treg cells
in the thymus because it induced a unique proapo-
ptotic protein signature (Puma++p-Bim++p-JNK++
DUSP6) and repressed expression of prosurvival
Bcl-2 molecules. However, Foxp3 lethality was pre-
vented by common gamma chain (gc)-dependent
cytokine signals that were present in the thymus in
limiting amounts sufficient to support only 1 million
Treg cells. Consequently, most newly arising Treg
cells in the thymus were deprived of this signal and
underwent Foxp3-induced death, with Foxp3+CD25
Treg precursor cells being the most susceptible.
Thus, we identify Foxp3 as a proapoptotic protein
that requires developing Treg cells to compete with
one another for limiting amounts of gc-dependent
survival signals in the thymus.
INTRODUCTION
Developing T cells express antigen receptors (TCRs) with diverse
recognition specificities that are then screened in the thymus for
usefulness and autoreactive potential. Thymocytes with useful
TCR specificities are positively selected to differentiate into func-
tionally mature CD4+ or CD8+ T cells, whereas thymocytes with
autoreactive TCRspecificities are negatively selected to undergo
clonal deletion (Pobezinsky et al., 2012; Singer et al., 2008; Starr
et al., 2003). Because thymic selection is imperfect, some poten-
tially autoreactive T cells manage to escape into the periphery
where their autoreactive potential must be suppressed. Regula-
tory T (Treg) cells are a specialized subpopulation of CD4+ T cells
that prevent activation of autoreactive T cells (Josefowicz et al.,
2012; Sakaguchi et al., 2008) so that animals lacking functional
Treg cells develop severe autoimmunity and succumb to early
death (Brunkow et al., 2001; Fontenot et al., 2003). The charac-1116 Immunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc.teristic feature of Treg cells is their expression of the forkhead
family transcription factor Foxp3 (Fontenot et al., 2003; Hori
et al., 2003) whose function is incompletely understood, with little
known about its effects on Treg cell viability.
For unclear reasons, there are striking similarities between the
requirements for clonal deletion and Treg cell generation in the
thymus. For example, Treg cells resemble clonally deleted thy-
mocytes in their expression of autoreactive TCRs (Apostolou
et al., 2002; Hsieh et al., 2004; Jordan et al., 2001), although
autoreactive TCRs on Treg cells may be of somewhat lower
affinity (Lee et al., 2012). Moreover, clonal deletion and Treg
cell generation both require CD28 costimulation (Pobezinsky
et al., 2012; Salomon et al., 2000; Tai et al., 2005). In developing
Treg cells, CD28 costimulation induces Foxp3 expression, prob-
ably through NF-kB activation and binding of c-Rel to noncoding
sequence elements in the Foxp3 gene (Isomura et al., 2009; Long
et al., 2009; Zheng et al., 2010). Interestingly, Treg cells are the
only CD4+ T cells to survive CD28 costimulation in the thymus
(Pobezinsky et al., 2012). Reciprocally, defects in the Bcl-2-regu-
lated apoptotic pathway that impair clonal deletion dispropor-
tionately increase Treg cell numbers in the thymus (Zhan et al.,
2011). These findings indicate an inverse relationship between
clonal deletion and Treg cell generation and suggest that
Foxp3 proteins might enhance cell viability.
Alternatively, Treg cells are unique among newly arising CD4+
thymocytes in expressing CD25, a component of the high-affinity
IL-2 receptor, and in requiring cytokine signals (Bayer et al.,
2008; Fontenot et al., 2005; Kra¨mer et al., 1995; Malek et al.,
2002;McCaughtry et al., 2012; Vang et al., 2008).Without signals
induced by common g chain (gc)-dependent cytokines, newly
arising Treg cells are markedly reduced in the thymus. Indeed,
the thymus of gc-deficient mice is virtually devoid of Treg cells
(Bayer et al., 2008; Burchill et al., 2007; Fontenot et al., 2005).
Although gc-mediated cytokines have been shown to signal
developing Treg cells to express Foxp3 (Burchill et al., 2008;
Lio and Hsieh, 2008), they also promote Treg cell survival.
From this alternative perspective, it is possible that Foxp3 pro-
teins impair cell viability and may be the reason that Treg cells
require gc cytokine signals for survival.
The present study was undertaken to determine what effect, if
any, Foxp3 protein expression actually has on cell viability. We
report that Foxp3 is a potently proapoptotic transcription factor
that is lethal to Treg cells unless its proapoptotic effects are
Figure 1. Foxp3 Expression Promotes Cell
Death
(A) Heterozygous B6xScurfy female mice with a
Foxp3GFP reporter transgene (Zhou et al., 2008)
contain two Treg cell subpopulations that express
(Xwt) or lack (Xsfy) functional Foxp3 proteins. The
frequency of each Treg cell subpopulation in the
thymus, as well as their expression of intracellular
Foxp3, intracellular CTLA-4, and surface CD25 is
shown (left and middle). Right panel displays the
relative percentage of each Treg cell subpopula-
tion that survived in overnight culture. Mean ± SE
of three mice aged 4–6 weeks.
(B) Foxp3 expression in thymocytes from Foxp3Tg
mice (A10, C10, and T3) and B6 CD4SP thymo-
cytes displayed as mean fluorescence intensity
(MFI). Data are representative of multiple experi-
ments.
(C) Thymocyte numbers from age-matched B6
and Foxp3Tg mice. Mean ± SE of ten mice.
(D) Quantitation of TUNEL+ cells in thymic sections
from the indicated mice. Mean ± SE of triplicate
samples in two experiments.
(E) Spontaneous thymocyte apoptosis in overnight
medium culture. Frequencies of EtBr+ DP and
CD4SP thymocytes from indicated mice were
normalized to control B6, which was set equal
to 0. Mean ± SE of triplicate cultures in three
experiments.
(F) Thymocyte numbers from the indicated mice.
Mean ± SE of 14 age-matchedmice in each group.
(G) Foxp3 protein expression in DP and CD4SP
thymocytes (left) and frequency of apoptotic cells
after overnightmediumculture (right, mean ±SE of
triplicate cultures). Data are representative of three
experiments.
(H) Spleen CD4+ T cell numbers from B6 and
Foxp3Tg mice. Mean ± SE of six mice per group.
*p < 0.01; ***p < 0.0001. See also Figure S1.
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kines. Thymocytes most prone to Foxp3-induced apoptosis
are Foxp3+CD25 Treg precursor cells, which do not require
gc-mediated signals to arise but do require gc cytokine signals
to survive and complete their differentiation into mature Treg
cells. As a result, newly arising Foxp3+ thymocytes must
compete for limiting amounts of cytokine survival signals, with
the result that most succumb to Foxp3-induced cell death.
Thus, this study identifies a lethal function of Foxp3 that explains
the strict requirement of Treg cells for gc-mediated survival
signals and alters understanding of Treg cell generation in the
thymus.
RESULTS
Foxp3 Induces Cellular Apoptosis
We first assessed the potential effects of Foxp3 on cell viability in
heterozygous B6xScurfy female mice that contain two distinctImmunity 38, 1116–112Treg cell subpopulations. Because of
random X chromosome inactivation,
B6xScurfy female mice contain a Treg
cell subpopulation that expresses func-tional Foxp3 proteins from the Xwt chromosome and another
Treg cell subpopulation that expresses unstable mutant Foxp3
proteins from the Xsfy chromosome. Expression of the Foxp3GFP
reporter transgene induced both Treg cell subpopulations to be
GFP+ cells (Zhou et al., 2008). We then distinguished the two
GFP+ Treg cell subpopulations from one another by intracellular
staining with anti-Foxp3 that identified Xwt Treg cells as Foxp3+
and Xsfy Treg cells as Foxp3/lo (Figure 1A, left and middle).
Instead of containing equal numbers of Xwt and Xsfy Treg cells,
80% of GFP+CD4SP thymocytes were Foxp3+ (Xwt) whereas
only 20% were Foxp3 (Xsfy) Treg cells (Figure 1A, left). Such
skewing in B6xScurfy female mice has been observed by others
(Gavin et al., 2007; Lin et al., 2007) and was due, at least in part,
to unstable and transient Foxp3GFP expression in Xsfy Treg cells
because they lack functional Foxp3 proteins to maintain Foxp3
gene expression (Zheng et al., 2010). Although lacking functional
Foxp3 proteins, Xsfy CD4SP thymocytes were Treg lineage cells
because, in addition to expressing Foxp3GFP, they expressed8, June 27, 2013 ª2013 Elsevier Inc. 1117
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Foxp3 Is ProapoptoticCTLA-4 and CD25 proteins, albeit in lower amounts than Xwt
Treg cells containing functional Foxp3 proteins (Figure 1A,
middle; Gavin et al., 2007; Lin et al., 2007). Most importantly,
Xwt and Xsfy Treg cells differed in their susceptibility to sponta-
neous cell death, with significantly fewer Xwt Treg cells surviving
in overnight culture than Xsfy Treg cells (Figure 1A, right). These
findings indicate that functional Foxp3 proteins increase suscep-
tibility to spontaneous cell death.
To directly determine the effect of Foxp3 proteins on cell
viability, we generated three lines of Foxp3 transgenic (Foxp3Tg)
mice (A10, C10, and T3) that expressed different amounts of
functional Foxp3 proteins, ranging from 40% to 110% of endog-
enous Foxp3 protein expression (Figure 1B). Unlike endogenous
Foxp3 proteins that were expressed by 3% of CD4SP thymo-
cytes, the Foxp3 transgenes A10 and C10 were driven by human
CD2 (hCD2) promoter-enhancer elements that induced Foxp3
expression in nearly all thymocytes (Figure S1A available online).
In contrast, the Foxp3 transgene T3 was driven by E8III-CD8a
promoter-enhancer elements (Sarafova et al., 2005) that actively
induced Foxp3 expression only in preselection DP thymocytes
(Figure S1A). We found that thymus cellularity was reduced in
Foxp3Tg mice (Khattri et al., 2001) and that the reduction
occurred in a Foxp3 dose-dependent manner (Figure 1C), indi-
cating an effect of Foxp3 on cell viability.
To analyze the thymus of Foxp3Tg mice, we performed in situ
TUNEL assays of thymic slices that revealed 5-fold more
apoptotic cells in Foxp3Tg than B6 thymi (Figures 1D and
S1B). Many of the Foxp3Tg thymocytes (both DP and CD4SP)
that were viable in vivo nevertheless underwent spontaneous
apoptosis after only a few hours in culture as determined by
ethidium bromide (EtBr) staining (Figure 1E). Foxp3Tg thymo-
cytes were protected from apoptosis by Bcl-2 overexpression
as transgenic expression of human Bcl-2 (hBcl-2) reduced
TUNEL+ apoptotic cells (Figure 1D), prevented spontaneous
death of Foxp3Tg thymocytes (Figure 1E), and significantly
increased in vivo thymus cellularity in Foxp3Tg mice (Figure 1F).
The protective effect of Bcl-2 suggested that Foxp3 expression
resulted in mitochondrial membrane damage, which was sub-
stantiated by low DiOC6 staining in Foxp3Tg thymocytes that
was corrected by Bcl-2 overexpression (Figure S1C).
To document that spontaneous death of Foxp3Tg thymocytes
was due to expression of functional Foxp3 proteins, we com-
pared DP and CD4SP thymocytes from C10 and T3 Foxp3Tg
mice for susceptibility to cell death (Figure 1G). Reflecting the
different expression patterns of the C10 and T3 transgenes
in vivo (Figure S1A), transgenic Foxp3 protein expression was
increased in C10 mice but terminated in T3 mice during differen-
tiation of DP into CD4SP thymocytes (Figure 1G, left). Impor-
tantly, termination of Foxp3 expression reversed susceptibility
of T3 CD4SP thymocytes to spontaneous cell death (Figure 1G,
right). In vivo cell numbers confirmed this point: T3 mice con-
tained 6-fold more peripheral splenic CD4+ T cells than did
C10 mice (Figure 1H) despite having fewer thymocytes (Fig-
ure 1C). Thus Foxp3 protein expression was associated with
cell death.
Identification of a Foxp3 Proapoptotic Protein Signature
To understand the basis for the lethal effects of Foxp3, we exam-
ined the effect of Foxp3 on the proapoptotic molecules Puma1118 Immunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc.and Bim because the first intron of the Bbc3 gene (which
encodes Puma) and the promoter region of the Bcl2l1 gene
(which encodes Bim) contain forkhead family consensus DNA
binding sequences (Gilley et al., 2003; Sunters et al., 2003; You
et al., 2006). We found that Foxp3Tg expression quantitatively
increased Puma expression (both mRNA and protein; Figures
2A and 2B) but did not increase Bim expression (either mRNA
or protein; Figures 2B and S2A), even in hBcl-2Tg thymocytes
with improved survival (Figure 2B). Although Bim proteins were
not quantitatively increased, we found that Bim proteins were
phosphorylated in Foxp3Tg thymocytes, as seen by an upward
mobility shift in SDS-PAGE that was reversed by l-phosphatase
treatment (Figures 2B and S2B). Notably, expression of other
proapoptotic proteins such as Bad were not altered by Foxp3
(Figure S2C). Thus, Foxp3 increased Puma expression but
induced Bim protein phosphorylation.
Bim proteins can be phosphorylated by either ERK or JNK
MAP kinases with different consequences (Ley et al., 2005).
ERK-mediated Bim phosphorylation targets Bim proteins for
ubiquitylation and proteasomal degradation, thereby decreasing
mitochondrial membrane damage and increasing cell survival. In
contrast, JNK-mediated Bim phosphorylation disrupts Bim inter-
action with the dynein motor complex and induces Bim translo-
cation to the mitochondria where it increases mitochondrial
membrane damage and decreases cell survival (Ley et al.,
2005). To determine whether Bim phosphorylation was induced
by ERK or JNK, thymocyte lysates from Foxp3Tg and wild-
type thymocytes were immunoblotted for p-ERK and p-JNK,
revealing that Foxp3Tg lysates contained elevated amounts of
p-JNK1 and p-JNK2 but not p-ERK (Figures 2B and S2D).
Thus, Bim phosphorylation in Foxp3Tg thymocytes was medi-
ated by p-JNK and so was proapoptotic.
Because Foxp3 is a transcription factor and not a protein
kinase, JNK phosphorylation in Foxp3Tg thymocytes was prob-
ably due to a Foxp3 target gene that encoded a regulatory kinase
or phosphatase. In this regard, we considered that JNK phos-
phorylation was reportedly increased by reduced expression
of dual specific phosphatases (DUSPs) that dephosphorylate
both p-threonine and p-tyrosine residues (Chi et al., 2006; Liu
et al., 2007). In fact DUSP1, DUSP5, and DUSP6 mRNA tran-
scripts were highly expressed in wild-type and hBcl-2Tg thymo-
cytes, but their expression was markedly diminished in Foxp3Tg
thymocytes (Figure 2C). Expression of DUSP6 protein, the only
DUSP protein we could unambiguously detect by immunoblot-
ting, was undetectable in Foxp3Tg thymocytes (Figure 2B). We
reasoned that if Foxp3 transgenic proteins directly downregu-
lated DUSP6 expression, then DUSP6 proteins, which were
absent in all Foxp3Tg DP thymocytes, would specifically reap-
pear in T3 SP thymocytes that terminated Foxp3 expression.
This is precisely what we observed (Figure S2E). Thus, Foxp3
proteins inhibited DUSP gene and protein expression and
increased phosphorylation of JNK and Bim proteins.
To better understand the inhibition by Foxp3 of DUSP gene
expression, we examined the promoter region of DUSP6 and
found that it contained putative forkhead family consensus
DNA binding sequences (Figure S2F; Marson et al., 2007). To
determine whether Foxp3 inhibited DUSP6 promoter activity,
we constructed a luciferase reporter that was driven either by
DUSP6 or DUSP6-M3 promoter sequences with mutations of
Figure 2. Effect of Foxp3 on Proapoptotic
and Prosurvival Molecules
(A) PumamRNAexpression inDP thymocytes from
indicated mice. Mean ± SE of triplicate samples.
(B) DP thymocyte expression of proapoptotic
proteins. Numbers in protein immunoblots refer to
intensities of the indicated bands relative to B6
(i.e., Foxp3TghBcl-2Tg), which was set equal to
1.0. Data are representative of three experiments.
(C) DUSP mRNA expression in DP thymocytes.
Mean ± SE of triplicate samples in three experi-
ments.
(D) Cotransfection of HeLa cells with a luciferase-
encoding vector (pGL3) driven either by the
DUSP6 or mutated DUSP6-M3 promoter,
together with either a Foxp3-encoding or empty
control vector (pcDNA3.1). DUSP6 promoter
activity was determined 24 hr after transfection by
relating luciferase activity to control renilla activity
to normalize for transfection efficiency. Mean ± SE
of triplicate samples in five experiments.
(E) Thymus cellularity in mice expressing the A10
Foxp3Tg (left) or not (right). Mean ± SE of five mice
per group.
(F) Effect of proapoptotic gene deficiencies on
Foxp3-dependent spontaneous apoptosis in
overnight culture. Frequency of EtBr+ cells after
overnight culture of DP thymocytes from A10
Foxp3Tg mice was normalized to that from the
identical mice without the A10 Foxp3Tg. Mean ±
SE of triplicate samples in three experiments.
(G) Effect of Foxp3 on endogenous Bcl-2 protein
expression. mBcl-2 content (determined by
intracellular staining) in thymocytes from mice
with the C10 Foxp3Tg normalized to mice without
it. Mean ± SE of four mice per group.
(H) Quantitative RT-PCR analysis of mBcl-2 mRNA
in thymocytes from the indicated mice. Mean ± SE
of triplicate samples in two experiments.
(I) mBcl-2 promoter activity was determined in
HeLa cells 24 hr after cotransfection with a
luciferase-encoding vector (pGL3) driven by the
mBcl-2 promoter, together with a vector
(pcDNA3.1) encoding either Flag-tagged wild-
type or truncated Foxp3 proteins. Anti-Flag
immunoblots confirmed the presence of Flag-
tagged Foxp3 proteins. Mean ± SE of triplicate
samples in three experiments.
**p < 0.001; ***p < 0.0001. See also Figure S2.
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and S2F). As assessed 24 hr after HeLa cell transfection, co-
transfection with Foxp3 inhibited DUSP6, but not DUSP6-M3,
promoter activity (Figure 2D), indicating that Foxp3 proteins
directly downregulated DUSP6 gene expression, a result consis-
tent with Foxp3 occupancy of the DUSP6 gene that was
observed previously (Marson et al., 2007). We also found that
cotransfection with Foxp3 DNA, compared to control pcDNA,
induced HeLa cell death after 24 hr, as was reported in MCF-7
cells (Figure S2G; Zuo et al., 2007).
These findings revealed that Foxp3 was proapoptotic and
increased Puma expression and Bim activity. We then deter-
mined the involvement of Puma and Bim in Foxp3-induced cell
death by making Foxp3Tg mice deficient in one or both mole-
cules. Deficiency of either Puma or Bim increased in vivonumbers of Foxp3Tg thymocytes, but maximal in vivo numbers
required double deficiency of both Puma and Bim (Figure 2E,
left). Similarly, deficiency of Puma or Bim reduced spontaneous
Foxp3-dependent cell death in vitro, but maximal reduction
required deficiency of both Puma and Bim (Figure 2F). Note
that Puma and/or Bim deficiency reduced spontaneous
apoptosis of Foxp3Tg thymocytes to a substantially greater
extent than that of non-Foxp3Tg thymocytes (Figure S2H). This
analysis revealed that Foxp3-induced apoptosis involved Puma
and Bim and identified a Foxp3-induced proapoptotic protein
signature abbreviated as Puma++p-Bim++p-JNK++DUSP6.
Foxp3 Inhibition of Bcl-2 Expression
Having identified a Foxp3 proapoptotic protein signature, we
examined the effect of Foxp3 on prosurvival proteins Bcl-xLImmunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc. 1119
Figure 3. Normal Treg Cells Display the
Foxp3 Proapoptotic Protein Signature
(A and B) Protein immunoblots of conventional
(Foxp3CD25) and regulatory (Foxp3+CD25+)
CD4SP thymocytes from B6 (A) and hBcl-2Tg (B)
mice containing the Foxp3-GFP reporter (Bettelli
et al., 2006). Puma mRNA (A, bottom) was deter-
mined by quantitative RT-PCR relative to 18S
rRNA (mean ± SE of triplicate samples). Data in (A)
are representative of two experiments and data in
(B) of four experiments.
(C) Intracellular mBcl-2 expression in Treg cell
subpopulations (Xwt and Xsfy) in the thymus of
heterozygous B6xScurfy female mice expressing
the Foxp3GFP reporter. Dashed lines represent
negative control staining. Data are representative
of two experiments.
(D) Frequency (left) and relative number of
Foxp3+CD4SP thymocytes compared to B6
(right). Mean ± SE of five to ten mice per group.
*p < 0.01; **p < 0.001; ***p < 0.0001. See also
Figure S3.
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2 is expressed only in SP thymocytes and is their major prosur-
vival protein (Boise et al., 1993; Sentman et al., 1991). Expression
of Bcl-xL proteins was not altered in Foxp3Tg mice (Figure S2I),
but expression of endogenous murine Bcl-2 (mBcl-2) proteins
was reduced (Figures 2G and S2J). Endogenous mBcl-2 protein
and mRNA levels were even more dramatically reduced in
Foxp3Tg thymocytes with hBcl-2Tg, presumably because
hBcl-2Tg maintained Foxp3Tg thymocytes with low mBcl-2
levels that otherwise failed to survive (Figures 2G, 2H, and S2J).
To determine whether Foxp3 proteins influenced Bcl2 pro-
moter activity, we performed transient transfections of HeLa
cells with a Bcl2 promoter luciferase construct and observed
that cotransfection with Flag-tagged Foxp3 significantly in-
hibited Bcl2 promoter activity (Figure 2I). We also performed co-
transfection experiments with constructs encoding Flag-tagged
Foxp3 deletion mutants lacking the C-terminal DNA binding
domain (Foxp3-DFKH), the N-terminal repressor domain
(Foxp3-DN), or both domains (Foxp3-DNFK) (Figure S2K; Koh
et al., 2009). Only intact Foxp3 molecules suppressed Bcl2 pro-
moter activity (Figure 2I), documenting that inhibition ofBcl2 pro-
moter activity required Foxp3 proteins with the forkhead DNA1120 Immunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc.binding domain and the Foxp3 repressor
domain, results consistent with occu-
pancy by Foxp3 of the Bcl2 promoter re-
gion (Katoh et al., 2011).
Our results demonstrate that trans-
genic Foxp3 proteins are potent inducers
of apoptosis that both upregulate proap-
optotic factors and downregulate prosur-
vival factors.
Induction of the Proapoptotic
Protein Signature by Endogenous
Foxp3
It was important to determine whether
endogenous Foxp3 proteins, like trans-genic Foxp3 proteins, upregulated proapoptotic factors and
repressed prosurvival factors. Compared to conventional
(Foxp3) CD4SP B6 thymocytes, Treg cells contained increased
Puma mRNA, increased p-Bim, increased p-JNK, and nearly
absent DUSP6 protein (Figure 3A), all of which were concordant
with the Foxp3 proapoptotic signature that we had identified in
Foxp3Tg thymocytes. Expression of the Foxp3 protein signature
(Puma++p-Bim++p-JNK++DUSP6) was even better appreciated
in Treg cells from hBcl-2Tg mice, presumably because the
hBcl-2Tg maintained cells that otherwise died from Foxp3-
induced apoptosis (Figure 3B).
Because Treg cells were generated in the thymus by high-
affinity TCR engagements, it might be argued that the proapo-
ptotic protein signature was not induced in Treg cells by Foxp3
but was induced by high-affinity TCR engagements in the
thymus. Consequently, we examined CD4SP thymocytes from
AND TCR transgenic mice that were Rag2/ on a B6xB10.A
background and that had encountered their agonist ligand,
pigeon cytochrome c (PCC) presented by I-Ek (Figure S3). How-
ever, the vast majority of PCC-I-Ek-signaled AND thymocytes
remained Foxp3 and did not display the Foxp3 proapoptotic
protein signature (Figure S3). Instead they displayed a very
Figure 4. Effect of IL-2 on Bcl-2 Expression
and Survival of Thymic Treg Cells
(A) Intracellular mBcl-2 expression in CD4SP thy-
mocytes from B6 mice. Data are representative of
six experiments.
(B) Intracellular mBcl-2 expression in Foxp3+
CD4SP thymocytes of Il2/ origin from intact
Il2/ mice and B6+Il2//B6 mixed donor
chimeras (left). Frequencies of Il2/ origin
Foxp3+CD4SP thymocyte subsets are also shown
(right). Mean ± SE of six mice per group.
(C) Spontaneous thymocyte apoptosis in over-
night culture of Xwt and Xsfy Treg cells from B6 and
Scurfy male mice expressing the Foxp3GFP re-
porter. Frequencies of Foxp3GFP+CD4SP thymo-
cytes that were EtBr+ were normalized to
Foxp3GFPCD4SP thymocytes that were set equal
to 0. Mean ± SE of triplicate cultures in three
experiments.
(D) Survival of CD4SP thymocytes from
AND.Rag2/.PCC (on B6xB10.A background) in
overnight cultures. Mean ± SE of triplicate cultures
in three experiments.
(E) mBcl-2 protein expression in Foxp3+CD25
CD4SP thymocytes from mice expressing consti-
tutively active Stat5b transgenic molecules
(STAT5-CA) normalized to B6 mice, which was set
equal to 100. Mean ± SE of five mice per group.
(F) Frequency of Foxp3+ CD4SP thymocytes.
Mean ± SE of five mice.
**p < 0.001; ***p < 0.0001. See also Figure S4.
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DUSP6 proteins; unchanged p-JNK proteins; and unchanged
or decreased Puma mRNA (Figure S3).
To determine the effect of endogenous Foxp3 proteins on
prosurvival Bcl-2 proteins, we examined Bcl-2 expression in
thymic Treg cells from B6xScurfy female mice. Even though
the two Treg cell subpopulations were from the same mice
and had been generated by the same intrathymic signals,
endogenous Bcl-2 expression was substantially lower in
Foxp3+ (Xwt) than Foxp3 (Xsfy) Treg cells (Figure 3C), demon-
strating that functional Foxp3 proteins reduced endogenous
Bcl-2 expression.
Induction of the Foxp3 proapoptotic protein signature
together with reduced Bcl-2 expression raised the possibility
that many newly arising Foxp3+ thymocytes normally died in
the thymus. In fact, prevention of Foxp3-induced apoptosis
disproportionately increased Foxp3+ relative to Foxp3 CD4SP
thymocytes in both Puma-Bim double-deficient and hBcl-2Tg
mice (Figure 3D), as was reported recently but attributed to
altered clonal deletion (Zhan et al., 2011). Notably, whileImmunity 38, 1116–112Puma-Bim double deficiency and hBcl-
2Tg expression increased conventional
Foxp3CD4SP thymocyte numbers
2-fold, they disproportionately increased
Foxp3+CD4SP thymocyte numbers
8-fold (Figure 3D, right). As a result, their
frequency of Foxp3+CD4SP thymocytes
was increased to 14% compared to 4%
in wild-type mice (Figure 3D, left).Thus, endogenous Foxp3 proteins induce a distinct proapo-
ptotic protein signature that makes Foxp3+ thymocytes prone
to cell death.
gc-Mediated Cytokine Signals Rescue Treg Cells from
the Proapoptotic Effects of Foxp3
Treg cells are known to depend on gc signals stimulated by such
cytokines as IL-2, IL-7, and IL-15 (Bayer et al., 2008; Burchill
et al., 2007; Fontenot et al., 2005; Kim et al., 2012; Vang et al.,
2008). In fact, Foxp3+CD4SP thymocytes that were CD25+ and
contained phosphorylated Stat5 proteins as a result of in vivo
IL-2 signaling also contained more endogenous Bcl-2 than did
Foxp3+CD4SP thymocytes that were CD25 (Figures 4A and
S4). To demonstrate that signaling by in vivo IL-2 upregulated
Bcl-2 expression in Treg cells, we compared Treg cells that
had never been exposed to in vivo IL-2 with Treg cells that
had.We did so by comparing Il2/ Treg cells from IL-2-deficient
(Il2/) mice with genetically identical Il2/ Treg cells obtained
from IL-2-sufficient mixed donor bone marrow chimeras
(B6+Il2//B6) (Figure 4B). Comparing Il2/ Foxp3+CD4SP8, June 27, 2013 ª2013 Elsevier Inc. 1121
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the mixed chimeras had upregulated Bcl-2 and increased
Foxp3+CD25+ Treg cells without affecting Foxp3+CD25 Treg
cells (Figure 4B). Thus, in vivo IL-2 signaling overcame Bcl-2
repression in Foxp3+CD25+ Treg cells and increased their in vivo
frequency.
To directly assess IL-2’s ability to prevent Foxp3-induced
apoptosis, we compared the impact of IL-2 on spontaneous
apoptosis of Xwt and Xsfy Treg cells from B6 and scurfy male
mice (Figure 4C). Addition of IL-2 to overnight culture signifi-
cantly reduced spontaneous apoptosis of Foxp3+ (Xwt) Treg cells
to levels identical with that of Foxp3 (Xsfy) Treg cells (Figure 4C),
indicating that IL-2 prevented cell death from Foxp3-induced
apoptosis. To assess this same issue in a different way, we
took advantage of the fact that, among CD4SP thymocytes in
AND-PCC double transgenic mice that were on a Rag2-deficient
B6xB10.A background, 8%were Foxp3+ and 92%were Foxp3
even though all AND CD4SP thymocytes had been signaled by
identical PCC-I-Ek complexes in vivo. Only 20% of the Foxp3+
AND thymocytes survived in overnight culture compared to
70% of the Foxp3 AND thymocytes (Figure 4D). Most impor-
tantly, IL-2 improved the survival of Foxp3+ AND thymocytes
to the identical level as Foxp3 AND thymocytes (Figure 4D),
demonstrating that IL-2 cytokine signaling prevented Foxp3-
induced apoptosis.
Having learned that IL-2 signaling increased Bcl-2 expression
and prevented Foxp3-induced apoptosis, it would be expected
that in vivo Treg cell frequencies would be increased by
increased IL-2 signaling. In fact, transgenic expression of consti-
tutively active transgenic STAT5b molecules, a downstream
effector of gc-mediated cytokine signaling, increased endoge-
nous Bcl-2 expression in Foxp3+CD25CD4SP thymocytes
and increased in vivo Treg cell frequencies (Figures 4E and
4F), the latter reported previously (Burchill et al., 2007). Notably,
constitutively active STAT5b transgenic mice displayed the
same disproportionately high thymic Treg cell frequencies
(16%) (Figure 4F) as found in hBcl-2Tg and in Puma- and
Bim-deficient mice (Figure 3D).
Effect of gc Deficiency on Generation of Foxp3+CD4SP
Thymocytes
Because IL-2 signaling prevented Foxp3-induced apoptosis
and because increased gc signaling increased thymic Treg
cells, it might be inferred that gc-dependent cytokines were
not present in sufficient amounts to signal all Foxp3+ thymo-
cytes to survive. However, such a conclusion would require
that thymocytes could express Foxp3 without having been
cytokine signaled, which conflicts with the prevailing view
that IL-2 signals are required to induce Foxp3 expression
(Burchill et al., 2008; Lio and Hsieh, 2008). Consequently,
we experimentally examined whether gc-dependent cytokine
signals were necessary for Foxp3 expression in developing
thymocytes.
To do so, we introduced the hBcl-2Tg or Bim deficiency into
gc-deficient Il2rg/ mice that otherwise contained very few
Treg cells or other thymocytes (Figure 5A; Bayer et al., 2008;
Burchill et al., 2007; Fontenot et al., 2005). However, Il2rg/
mice with either the hBcl-2Tg or Bim deficiency contained signif-
icantly more Foxp3+CD4SP thymocytes (Figure 5A), document-1122 Immunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc.ing that gc signals were not required for Foxp3 expression if
thymocytes were protected from Foxp3-induced apoptosis.
Interestingly, the Foxp3+CD4SP thymocytes that were present
in Il2rg/ mice were phenotypically CD25 (Figure 5A). To
confirm these findings in mice with physiologic numbers of
thymocytes, we conditionally deleted gc in preselection DP
thymocytes in mice containing floxed Il2rg alleles and the E8IIICre
transgene (McCaughtry et al., 2012). We confirmed that DP thy-
mocytes and their CD4SP progeny in E8IIICre-Il2rgfl/fl mice lacked
gc expression (Figure 5B, left). gc deficiency abrogated the
appearance of Foxp3+CD4SP thymocytes but did not effect
Foxp3CD4SP thymocyte numbers (Figure 5B, middle). As in
germline Il2rg/ mice, the hBcl-2Tg restored Foxp3+CD4SP
thymocyte numbers (Figure 5B, middle) and the rescued Foxp3+
CD4SP thymocytes were CD25 (Figure 5B, right). Thus,
Foxp3+CD4SP thymocytes can arise without gc-dependent
cytokine signals but, in the absence of gc-dependent cytokine
signals, the Foxp3+ cells remain CD25 and susceptible to
Foxp3-induced cell death.
We then assessed whether Foxp3+CD25 cells participate in
normal Treg cell development by differentiating into mature
Foxp3+CD25+ cells in the thymus. In principle, mature Foxp3+
CD25+ cells could arise from CD4SP (Foxp3CD25) thymo-
cytes along two developmental pathways: (1) by upregulation
of Foxp3 to become Foxp3+CD25 precursors that rely on IL-2
signals to survive and differentiate into mature Treg cells (i.e.,
Foxp3CD25/Foxp3+CD25/Foxp3+CD25+) and (2) by up-
regulation of CD25 to become Foxp3CD25+ precursors that
must then be signaled by IL-2 to express Foxp3 and differentiate
into mature Treg cells (i.e., Foxp3CD25/Foxp3CD25+/
Foxp3+CD25+). In fact both Foxp3+CD25 and Foxp3CD25+
putative precursors were in normal B6 mice (Figure 6A, top),
with the current view being that mature Treg cells arise only
from Foxp3CD25+ precursors in response to IL-2 signaling
(Burchill et al., 2008; Lio and Hsieh, 2008). However, analysis
of intermediates along the Foxp3+CD25 precursor pathway re-
vealed that surface CD24 expression progressively declined
whereas surface Qa-2 and GITR expression progressively
increased, to become Foxp3+CD25+ mature Treg cells (Fig-
ure 6A, bottom), suggesting that mature Treg cells also devel-
oped from Foxp3+CD25 precursors.
To determine whether Foxp3+CD25 precursors could actu-
ally differentiate into mature Treg cells, we placed them in over-
night culture with IL-2 and found that they differentiated into
Foxp3+CD25+ thymocytes even more extensively than did
Foxp3CD25+ precursors (Figure 6B). To see whether Foxp3+
CD25 precursors differentiated into mature Treg cells in vivo,
we adoptively transferred Foxp3+CD25 and Foxp3CD25+
CD4 cells that were CD45.2 (along with Foxp3CD25 CD4
cells that were CD45.1 as an in vivo source of IL-2) into unirra-
diated Rag2/ host mice (Figure 6C). Three weeks later,
Foxp3+CD25 cells had differentiated into Foxp3+CD25+
mature Treg cells, with 90% of the mature Treg cells derived
from Foxp3+CD25 precursors and 10% from Foxp3CD25+
precursors, even though total CD45.2 CD4 T cells in host
mice were derived almost equally from both (Figures 6C and
S5A). Notably, mature Treg cells derived from Foxp3+CD25
precursor cells were functionally suppressive in vitro (Fig-
ure S5A, bottom).
Figure 5. gc-Independent Expression of Foxp3
(A) Foxp3+CD4SP thymocytes in germline Il2rg/ (gc-deficient) mice. Numbers in histograms indicate frequency of cells within box. Mean ± SE of five to eight
mice per group.
(B) gc expression and its effect on DP and CD4SP thymocytes from the indicated mice. Numbers in histograms indicate frequency of cells within box. Mean ± SE
of six mice per group.
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but they require gc-mediated cytokine signals to survive and
differentiate into mature Foxp3+CD25+ Treg cells.
Competition for gc-Dependent Cytokines
Having determined that Foxp3+CD25 precursors can differen-
tiate into Foxp3+CD25+ mature Treg cells, we examined how
they were affected by hBcl-2Tg expression and Puma-Bim defi-
ciency. Both experimental maneuvers substantially increased
Foxp3+CD25 precursors by10- to 20-fold and modestly
increased Foxp3+CD25+ mature Treg cells by 3- to 6-fold but
had little effect on Foxp3CD25+ precursors (Figures 6D and
S5B). That Foxp3+CD25 precursors were markedly increased
by Bcl-2Tg expression and Puma-Bim deficiency and were
increased to a much greater degree than Foxp3+CD25+ mature
Treg cells indicated that (1) most Foxp3+CD25 precursors
normally fail to survive and (2) there is insufficient gc-mediated
signaling to support the differentiation of all Foxp3+CD25 pre-
cursors into Foxp3+CD25+ mature Treg cells. This reasoning
predicts a life-and-death competition among newly arising
Foxp3+CD25 thymocytes for limiting amounts of gc cytokine
signaling in the thymus.
To detect competition among Foxp3+ thymocytes for gc cyto-
kine signaling, we utilized the Foxp3Cre transgene (Zhou et al.,
2008) to delete gc expression only in Foxp3+ thymocytes in
Il2rgfl/fl mice (Figure 7A). In Foxp3Cre-Il2rgfl/fl mice, Foxp3+
CD4SP thymocytes were greatly reduced but were increasedby the hBcl-2Tg that rescued mainly Foxp3+CD25 precursor
cells (Figures 7A and S6A). As a result of their deficiency in
Foxp3+ cells, Foxp3Cre-Il2rgfl/fl mice suffered from aggressive
autoimmune disease with stunted growth, multiorgan lympho-
cytic infiltrations, and death at 3 weeks of age, whereas hBcl-
2Tg mice remained free of disease longer and survived until
6–7 weeks of age (Figures S6B–S6D).
To detect competition among Foxp3+ thymocytes for gc-
mediated survival signals, we constructed mixed donor
chimeras whose Foxp3+CD4SP thymocytes would be a
mixture of gc+ and gc-deficient (gcfl) cells. The chimeras were
designated B6+Foxp3Cre-Il2rgfl/fl/B6 and B6+Foxp3Cre-
Il2rgfl/fl.hBcl-2Tg/B6 and remained healthy because of B6
origin Treg cells. Importantly, B6 origin Treg cells were the only
Treg cells that expressed gc and would compete for gc-medi-
ated survival signals in these chimeras. Indeed, in these chi-
meras, Foxp3+ thymocytes of B6 origin were overwhelmingly
Foxp3+CD25+, indicating that they had received gc cytokine
signals, whereas gcflFoxp3+ thymocytes of Il2rgfl/fl origin were
mainly Foxp3+CD25 (Figure S6E). Analyzed 8–10 weeks after
construction, individual chimeras contained different numbers
of B6 and Il2rg/ origin CD4SP thymocytes (Figure 7B). Impor-
tantly, as the number of B6 donor origin CD4SP thymocytes
increased, the frequency of B6 origin CD4SP thymocytes that
were Foxp3+ declined (Figure 7B, top left) and their absolute
number plateaued at 0.8 million Foxp3+ cells per thymus (Fig-
ure 7B, top right). In contrast, gcfl cells in the same thymiImmunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc. 1123
Figure 6. Foxp3+CD25– Precursors of Foxp3+CD25+ Mature Treg Cells
(A) CD4SP thymocytes from Foxp3-GFP reporter mice (Bettelli et al., 2006) (top) and flow cytometric analysis of gated subsets (A–E) (bottom). Data are
representative of four experiments.
(B) In vitro differentiation of sorted Foxp3+CD25 and Foxp3CD25+ CD4SP thymocytes. Data are representative of six experiments.
(C) In vivo development of Foxp3+CD25+ Treg cells from two Treg precursor cell subsets. CD4 cells were electronically sorted into subsets of Foxp3-GFP+CD25
cells (A), Foxp3-GFPCD25+ cells (B), and Foxp3-GFPCD25 cells (C) as indicated (left) and transferred together into unirradiatedRag2/ host mice. Each host
mouse received 33 105 donor cells of (A), 13 105 donor cells of (B), and 13 106 donor cells of (C). After 3 weeks, host spleen and LN T cells were analyzed (right).
Data are representative of four host mice analyzed in two independent experiments.
(D) Effects of Puma-Bim double deficiency and hBcl-2Tg expression on precursor and mature thymic Treg cells. Each CD4SP thymocyte subset was compared
relative to B6 mice, which was set equal to 1. Mean ± SE of four to nine mice per group.
See also Figure S5.
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Figure 7. Newly Generated Foxp3+ Thymo-
cytes Compete for gc-Mediated Survival
Signals
(A) Effect of Foxp3-specific gc deletion on gc
expression (left) and Treg cell number (right) in
thymi of 3- to 4-week-old mice. Mean ± SE of four
to five mice per group.
(B) Frequency (left) and number (right) of Foxp3+
cells among CD4SP thymocytes in competitive
mixed donor chimeras. CD4SP thymocytes of B6
donor origin are gc+ (closed symbols) and dis-
played in top panels; CD4SP thymocytes of Il2rgfl/fl
donor origin are gcfl (open symbols) and displayed
in bottom panels. Each circle and square repre-
sents an individual mouse. The star indicates
intact B6 mice.
***p < 0.0001. See also Figure S6.
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CD4SP thymocytes increased, the frequency of Il2rgfl/fl origin
CD4SP thymocytes that were Foxp3+ was constant (Figure 7B,
bottom left) and their absolute number increased accordingly,
which was best appreciated in hBcl-2Tg thymocytes because
of their greater survival (Figure 7B, bottom).
Together, these results revealed that (1) gc+ Treg cells in the
thymus competed for gc-mediated survival signals and (2) the
thymus contained only enough gc cytokines to support fewer
than one million Foxp3+ thymocytes.
DISCUSSION
The present study provides a perspective on the impact and
sequence of Foxp3 expression during Treg cell development in
the thymus. Foxp3 induced a characteristic proapoptotic protein
signature that was lethal to developing Treg cells unless counter-
balanced by gc-mediated survival signals. However, gc-medi-
ated survival signals were present in the thymus in limiting
amounts that could support fewer than one million Foxp3+ cells.
As a result, most newly arising Foxp3+CD4SP thymocytes under-
went Foxp3-induced cell death. The cells most prone to dying
of Foxp3-induced apoptosis were Foxp3+CD25 thymocytes,
which strictly required gc-mediated signals for their survival
and further differentiation into mature Foxp3+CD25+ Treg cells.
Foxp3-induced apoptosis resulted from increased activity of
the proapoptotic proteins Bim and Puma and decreased expres-Immunity 38, 1116–112sion of the prosurvival protein Bcl-2.
Because the Foxp3 protein functions as
a transcription factor, it was readily un-
derstandable how Foxp3 could increase
Puma expression but it was unclear how
Foxp3 could induce Bim protein phos-
phorylation. We determined that it did
so by suppressing expression of at least
three members of the DUSP gene family
(DUSP1, DUSP5, DUSP6) that encode
dual specific phosphatases that function
as negative regulators of JNK kinases to
prevent JNK-induced Bim phosphoryla-
tion. Detailed analysis of the promoterregion of one DUSP gene (DUSP6) revealed conserved forkhead
family consensus binding motifs that were responsible for direct
suppression by Foxp3 of DUSP promoter activity. As a result,
expression of Foxp3 proteins resulted in a unique proapoptotic
protein signature that we characterized as Puma++p-Bim++
p-JNK++DUSP6. That this proapoptotic protein signature pro-
motes cell death was shown by significantly improved survival
of Foxp3+ cells in vivo in mice deficient in Puma and Bim.
Foxp3 was also shown to reduce Bcl-2 expression, and it did
so by reducing Bcl2 promoter activity. Reciprocally, transgenic
overexpression of Bcl-2 proteins prevented Foxp3-induced
apoptosis.
Genetic disruption of intracellular death pathways by either
transgenic overexpression of prosurvival proteins or deficient
expression of proapoptotic proteins rescued newly arising Treg
cells from Foxp3-induced cell death and revealed that the actual
frequency of newly arising Treg cells among CD4SP thymocytes
was substantially higher than the 3%–5% normally observed.
Notably, the basis for increased Treg cells in the thymus of
mice with impaired intracellular death pathways has been under-
stood quite differently by others (Zhan et al., 2011). In their study,
disruption of the Bcl-2-regulated apoptotic pathway was
thought to increase Treg cell frequency in the thymus as a conse-
quence of impaired TCR-signaled clonal deletion (Zhan et al.,
2011). In contrast, the present study documents that Foxp3 pro-
teins are themselves proapoptotic but require intact intracellular
death pathways to induce apoptosis. Indeed, Foxp3 was shown8, June 27, 2013 ª2013 Elsevier Inc. 1125
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(Puma++p-Bim++p-JNK++DUSP6) and to promote apoptosis
of all cell types in which Foxp3 was expressed, even cells that
never expressed or were never signaled by their TCR. Foxp3-
induced apoptosis was prevented by the gc-dependent cytokine
IL-2 or, experimentally, by Puma-Bim deficiency or hBcl-2 trans-
gene expression, which explains why Bim deficiency was previ-
ously found to restore appearance of Foxp3+ cells in the absence
of IL-2 signaling (Barron et al., 2010).
Even though gc-dependent cytokine signals are necessary for
Treg cell survival, we were surprised that the absolute number of
gc-sufficient Foxp3+ cells that could survive in an individual
thymus was fewer than one million. These findings revealed
that gc-dependent survival signals are not present in sufficient
amounts to support all newly arising Treg cells in the thymus,
so that most succumb to Foxp3-induced apoptosis. Conse-
quently, the frequency of gc+CD4SP thymocytes that expressed
Foxp3 in competitive chimeras increased substantially when the
absolute number was fewer than 1 million. Indeed, the fre-
quency of newly arising gc+ Treg cells in competitive chimeras
with fewer than 1 million competing gc+ Treg cells was as
high as that observed in Bcl-2Tg and PUMA-Bim double-defi-
cient mice. Consequently, in addition to competing for limiting
numbers of antigenic complexes (Bautista et al., 2009), newly
arising Treg cells must compete for limiting amounts of gc sur-
vival signals.
It has been thought that CD4 thymocytes developing into Treg
cells first upregulate CD25, a component of the high-affinity IL-2
receptor complex, to become Foxp3CD25+ precursors that are
then signaled by IL-2 to initiate Foxp3 expression and become
Foxp3+CD25+ mature Treg cells (Burchill et al., 2008; Lio and
Hsieh, 2008). Although we think that Foxp3CD25+ precursors
constitute one pathway by which mature Treg cells arise in the
thymus, the present study revealed another pathway in which
CD4 thymocytes first upregulate Foxp3 to become Foxp3+
CD25 precursors that are then subsequently signaled to
become Foxp3+CD25+ mature Treg cells. In fact, because
Puma-Bim deficiency and hBcl-2Tg expression mainly rescued
Foxp3+CD25 precursors, we think the Foxp3+CD25 precursor
pathway is a major pathway by which mature Treg cells develop
in the thymus.
Although Foxp3+CD25 precursors can be maintained by IL-7
signals (Bayer et al., 2008), we think their expression of Foxp3 is
the result of TCR-CD28 costimulation (Tai et al., 2005). Consis-
tent with this view, enhancement of NF-kB activity, which is a
downstream result of TCR-CD28 costimulation, markedly
increased Foxp3+CD25 precursors in the thymus (Long et al.,
2009). Because TCR-CD28 costimulation can also signal CD25
upregulation, it was conceivable that TCR-CD28 costimulation
also signaled Foxp3+CD25 precursors to express CD25 and
to become mature Treg cells. However, Foxp3+CD25 precur-
sors failed to become CD25+ in gc-deficient mice, even though
gc deficiency impairs neither TCR-CD28 costimulation nor
CD25 expression. Consequently, we think that Foxp3+CD25
precursors are induced to express CD25 by gc-mediated signals
transduced by intermediate affinity IL-2 bg receptor complexes.
In conclusion, the present study has revealed that Foxp3 is
proapoptotic and responsible for imposing cytokine depen-
dence on newly arising Treg cells. This study significantly alters1126 Immunity 38, 1116–1128, June 27, 2013 ª2013 Elsevier Inc.understanding of Treg cell generation in the thymus and provides
fundamental insights into their development.
EXPERIMENTAL PROCEDURES
Animals
Two Foxp3 reporters were utilized: Foxp3GFP referred to FoxP3-GFP-hCre
transgenic mice (Zhou et al., 2008) and Foxp3-GFP referred to Foxp3-GFP
knockin mice (Bettelli et al., 2006). All mice were cared for in accordance
with National Institutes of Health guidelines.
Foxp3 Transgenic Mice
cDNA encoding mouse Foxp3 was introduced into a hCD2-based vector to
generate Foxp3Tg lines A10 and C10 and was introduced into the E8III-
CD8a enhancer-promoter construct TG-31 (Sarafova et al., 2005) to generate
the Foxp3Tg line T3.
Targeting gc Deficiency to Foxp3+ Cells
Male conditional knockout mice with targeted deletion of gc in Foxp3+ cells
were generated by mating Il2rgfl/fl mice with Foxp3-GFP-hCre mice.
Bone Marrow Chimeras
Radiation bone marrow chimeras were constructed by reconstituting lethally
irradiated (950R) host mice with a total of 10–15 3 106 T cell-depleted bone
marrow cells 6 hr after irradiation. Chimeric mice were analyzed 8 weeks after
reconstitution.
In Vitro Cultures
23 106 thymocytes were cultured overnight in medium or rIL-2 (200 U/ml) and
then stained with EtBr. Relative frequency of EtBr+ cells was calculated as
follows: (%EtBr+ (experimental mice)  %EtBr+ (B6 mice))/(100  %EtBr+
B6 mice). For DiOC6 staining, DiOC6 was added to culture 30 min before
harvesting cells. Relative frequency of DiOC6lo cells was calculated with the
same formula as EtBr+.
Adoptive Transfer and In Vitro Functional Assays
Where indicated, Rag2/ mice were injected with three different CD45-
distinct CD4 subpopulations: (1) Foxp3-GFP+CD25 (3 3 105), (2) Foxp3-
GFPCD25+ (1 3 105), and (3) Foxp3-GFPCD25 (1 3 106). After 3 weeks,
donor origin LN and spleen cells were analyzed and assessed functionally
in suppression assays utilizing CFSE-labeled CD4+CD25 responder
T cells stimulated for 72 hr with anti-CD3 (1 mg/ml) in the presence of
added APCs.
Statistical Analysis
Two-tailed Student’s t test was used for statistical analyses. p values of 0.01 or
less were considered significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and one table and can be found with this article online at http://
dx.doi.org/10.1016/j.immuni.2013.02.022.
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